Inactive Instrument
Guided Therapeutics Inc Share Price OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 15/07 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| 16/06 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 2.62Cr 2.29Cr 2.13Cr 1.96Cr 3.69Cr 252.7Cr 3.74Cr 25Cr 9.93Cr 123.65Cr 9.83Cr 9.62Cr 427.16Cr | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.91Cr 2.55Cr 2.36Cr 2.17Cr 4.09Cr 280.46Cr 4.15Cr 28Cr 11Cr 137.23Cr 11Cr 11Cr 474.07Cr | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.57% | -1.65% | +23.11% | -7.88% | 19TCr | ||
| +0.06% | -10.79% | -5.68% | -30.57% | 13TCr | ||
| -2.68% | -12.41% | -33.33% | +5.29% | 12TCr | ||
| -0.51% | -0.16% | -58.35% | -17.63% | 6.42TCr | ||
| -0.21% | -3.32% | +10.58% | -7.69% | 4.87TCr | ||
| +0.17% | +0.82% | -24.52% | -32.66% | 4.38TCr | ||
| +0.45% | -0.93% | +14.86% | +4.49% | 3.75TCr | ||
| +0.89% | -1.09% | +29.00% | +29.22% | 3.61TCr | ||
| -0.86% | +1.99% | +87.07% | +1.49% | 2.91TCr | ||
| Average | -0.29% | -3.08% | +4.75% | -6.22% | 7.82TCr | |
| Weighted average by Cap. | -0.42% | -3.83% | -0.73% | -9.09% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7T 6.13T 5.69T 5.23T 9.86T 7L 10T 67.83T 26.55T 3L 26.28T 25.71T 11.42L | 8L 7L 6L 6L 10.8L 7.4Cr 10.96L 74.32L 29.09L 3.62Cr 28.79L 28.17L 13Cr |
| Net income | -24.17L -21.18L -19.66L -18.07L -34.04L -23Cr -34.54L -2.34Cr -91.67L -11Cr -90.73L -88.78L -39Cr | -31.96L -28L -26L -23.89L -45.01L -31Cr -45.68L -3.1Cr -1.21Cr -15Cr -1.2Cr -1.17Cr -52Cr |
| Net Debt | 17.71L 15.52L 14.41L 13.24L 24.94L 17Cr 25.31L 1.72Cr 67.17L 8.36Cr 66.48L 65.05L 29Cr | 28.76L 25.2L 23.39L 21.5L 40.51L 28Cr 41.1L 2.79Cr 1.09Cr 14Cr 1.08Cr 1.06Cr 47Cr |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















